Variable neurodevelopmental and morphological phenotypes of carriers with 12q12 duplications.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
01 2020
Historique:
received: 27 06 2019
revised: 18 09 2019
accepted: 25 09 2019
pubmed: 16 11 2019
medline: 30 3 2021
entrez: 16 11 2019
Statut: ppublish

Résumé

Variable size deletions affecting 12q12 have been found in individuals with neurodevelopmental disorders (NDDs) and distinct facial and physical features. For many genetic loci affected by deletions in individuals with NDDs, reciprocal duplications have been described. However, for the 12q12 region, there are no detailed descriptions of duplication cases in the literature. We report a phenotypic description of a family with monozygotic twins diagnosed with NDDs, carrying a 9 Mb duplication at 12q12, and five other individuals with overlapping duplications ranging from 4.54 Mb up to 15.16 Mb. The duplication carriers had language delays, cognitive delays, and were diagnosed with autism spectrum disorder. Additionally, distinct facial features (e.g., high foreheads, deeply set eyes, short palpebral fissures, small ears, high nasal bridges, abnormalities of the nose tip, thin lips), large feet, and abnormalities in the digits were noted. We also describe incomplete penetrance of the NDD phenotypes among the individuals with 12q12 duplication. This case series expands our knowledge on this rare genetic aberration and suggests that large 12q12 duplications may increase the risk for developing NDDs.

Sections du résumé

BACKGROUND
Variable size deletions affecting 12q12 have been found in individuals with neurodevelopmental disorders (NDDs) and distinct facial and physical features. For many genetic loci affected by deletions in individuals with NDDs, reciprocal duplications have been described. However, for the 12q12 region, there are no detailed descriptions of duplication cases in the literature.
METHODS
We report a phenotypic description of a family with monozygotic twins diagnosed with NDDs, carrying a 9 Mb duplication at 12q12, and five other individuals with overlapping duplications ranging from 4.54 Mb up to 15.16 Mb.
RESULTS
The duplication carriers had language delays, cognitive delays, and were diagnosed with autism spectrum disorder. Additionally, distinct facial features (e.g., high foreheads, deeply set eyes, short palpebral fissures, small ears, high nasal bridges, abnormalities of the nose tip, thin lips), large feet, and abnormalities in the digits were noted. We also describe incomplete penetrance of the NDD phenotypes among the individuals with 12q12 duplication.
CONCLUSION
This case series expands our knowledge on this rare genetic aberration and suggests that large 12q12 duplications may increase the risk for developing NDDs.

Identifiants

pubmed: 31730283
doi: 10.1002/mgg3.1013
pmc: PMC6978403
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1013

Informations de copyright

© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.

Références

Am J Hum Genet. 2014 May 1;94(5):677-94
pubmed: 24768552
PLoS One. 2013 Dec 03;8(12):e80737
pubmed: 24312498
Am J Med Genet B Neuropsychiatr Genet. 2019 Sep;180(6):341-350
pubmed: 30307693
Am J Med Genet A. 2018 Dec;176(12):2841-2845
pubmed: 30345727
Am J Med Genet A. 2016 Nov;170(11):2916-2926
pubmed: 27748065
Am J Med Genet A. 2010 Sep;152A(9):2394-8
pubmed: 20683996
Indian J Hum Genet. 2011 May;17(2):48-53
pubmed: 22090712
Am J Psychiatry. 2012 Feb;169(2):195-204
pubmed: 22420048
Sci Rep. 2018 Dec 21;8(1):18021
pubmed: 30575813
J Neurogenet. 2018 Dec;32(4):313-315
pubmed: 29790814
Am J Med Genet A. 2008 May 15;146A(10):1354-7
pubmed: 18412123
PLoS Genet. 2011 Nov;7(11):e1002334
pubmed: 22102821
Mol Psychiatry. 2017 Apr;22(4):625-633
pubmed: 27166760
Eur J Pharmacol. 2013 Nov 5;719(1-3):63-74
pubmed: 23872404
J Ultrasound Med. 2013 May;32(5):851-63
pubmed: 23620328
Mol Genet Genomic Med. 2020 Jan;8(1):e1013
pubmed: 31730283
Clin Med Insights Pediatr. 2016 Jul 14;10:67-83
pubmed: 27441006
Am J Med Genet A. 2015 Aug;167A(8):1890-6
pubmed: 25846056
BMC Med Genet. 2010 Sep 21;11:134
pubmed: 20858243
Dev Neurobiol. 2018 May;78(5):519-530
pubmed: 29575775
Hum Genet. 2017 Mar;136(3):297-305
pubmed: 28124119
Mol Autism. 2014 Jan 10;5(1):1
pubmed: 24410847
Am J Med Genet B Neuropsychiatr Genet. 2018 Jul;177(5):489-502
pubmed: 29687944
Neurogenetics. 2015 Oct;16(4):307-14
pubmed: 26238514
Sci Transl Med. 2011 Aug 10;3(95):95ra75
pubmed: 21832240
JAMA Psychiatry. 2016 Jan;73(1):20-30
pubmed: 26629640
Front Physiol. 2018 Sep 19;9:1278
pubmed: 30283344
Curr Psychiatry Rep. 2017 Sep 20;19(11):82
pubmed: 28929285
J Biol Chem. 2012 Feb 10;287(7):5033-41
pubmed: 22184115
Biol Psychiatry. 2015 May 1;77(9):785-93
pubmed: 25064419
Twin Res Hum Genet. 2014 Jun;17(3):164-76
pubmed: 24735654
Ann Hum Genet. 2018 Nov;82(6):482-487
pubmed: 30155906
Eur J Med Genet. 2019 Jan;62(1):27-34
pubmed: 29698805
Congenit Anom (Kyoto). 2006 Dec;46(4):177-9
pubmed: 17096817
Child Adolesc Psychiatry Ment Health. 2017 Nov 28;11:57
pubmed: 29209412
Twin Res Hum Genet. 2018 Feb;21(1):1-11
pubmed: 29307321

Auteurs

Lynnea Myers (L)

Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institutet & Child and Adolescent Psychiatry, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Moira Blyth (M)

Department of Clinical Genetics, Chapel Allerton Hospital, Leeds, UK.

Kamran Moradkhani (K)

CHU Nantes, Service de Génétique Médicale, Nantes, France.

Dubravka Hranilović (D)

Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia.

Sam Polesie (S)

Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Johan Isaksson (J)

Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institutet & Child and Adolescent Psychiatry, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Department of Neuroscience, Child and Adolescent Psychiatry and Psychiatry Unit, Uppsala University, Uppsala, Sweden.

Ann Nordgren (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

Maja Bucan (M)

Department of Genetics and Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Marie Vincent (M)

Centre Hospitalier, University of Nantes, Nantes, France.

Sven Bölte (S)

Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institutet & Child and Adolescent Psychiatry, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Curtin Autism Research Group, School of Occupational Therapy, Social Work and Speech Pathology, Curtin University, Perth, Western Australia, Australia.

Britt-Marie Anderlid (BM)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

Kristiina Tammimies (K)

Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institutet & Child and Adolescent Psychiatry, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH